Disease
3 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
This is a recruiting interventional study with no posted results; it represents early-phase work designed to assess feasibility and correlates rather than establish efficacy.
AUG 13, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
Phase 2 trial in bipolar depression with small sample (n=34) and surrogate endpoint (HAM-D); recruitment completed but no results posted in registry, limiting evidence strength.
AUG 10, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
This is an active Phase 1 proof-of-concept study with no results yet reported; it aims to characterize neurobiological mechanisms in a small, uncontrolled cohort rather than establish clinical efficacy.